Top-Rated Stocks NASDAQ:RCM R1 RCM - RCM Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $13.99 -0.14 (-0.99%) (As of 01/30/2023 11:45 AM ET) Add Compare Share Share Today's Range$13.79▼$14.1050-Day Range$7.39▼$14.1352-Week Range$6.71▼$27.86Volume546,133 shsAverage Volume3.21 million shsMarket Capitalization$5.83 billionP/E Ratio233.17Dividend YieldN/APrice Target$17.64 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability R1 RCM MarketRank™ ForecastAnalyst RatingModerate Buy2.92 Rating ScoreUpside/Downside27.8% Upside$17.64 Price TargetShort InterestHealthy11.62% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.66Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.15) to $0.26 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.87 out of 5 starsBusiness Services Sector79th out of 326 stocksManagement Services Industry1st out of 6 stocks 4.5 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.64, R1 RCM has a forecasted upside of 27.8% from its current price of $13.81.Amount of Analyst CoverageR1 RCM has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted11.62% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in R1 RCM has recently decreased by 9.03%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 3.1 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 8 news articles for R1 RCM this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for RCM on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat Follows4 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have not sold or bought any company stock.Percentage Held by Insiders63.50% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions97.09% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow in the coming year, from ($0.15) to $0.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of R1 RCM is 230.17, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 124.31.Price to Earnings Ratio vs. SectorThe P/E ratio of R1 RCM is 230.17, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 211.30.Price to Earnings Growth RatioR1 RCM has a PEG Ratio of 3.08. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 11.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About R1 RCM (NASDAQ:RCM) StockR1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.Read More Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Stock News HeadlinesJanuary 30, 2023 | finance.yahoo.comFollowing a 41% decline over last year, recent gains may please R1 RCM Inc. (NASDAQ:RCM) institutional ownersJanuary 30, 2023 | marketwatch.comHealthcare Business Process Outsourcing Market 2023 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2028January 30, 2023 | Investing Trends (Ad)"We need batteries. Literally everywhere."Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense." January 26, 2023 | finance.yahoo.comR1 RCM to Release Fourth Quarter 2022 Results on February 16January 25, 2023 | marketwatch.comForecast 2028 for the Revenue Cycle Management (RCM) System Market in terms of size, returns, gross margin, and market shareJanuary 21, 2023 | americanbankingnews.comR1 RCM (NASDAQ:RCM) Price Target Raised to $16.00January 18, 2023 | marketwatch.comHealthcare Business Process Outsourcing Market Major Segments, Size Parameters and Topmost Key Players - Accenture, R1 RCM, Allscripts, CapgeminiJanuary 15, 2023 | marketwatch.comHealthcare RCM Outsourcing Market Size 2023 with Identification of major companies working in the market with related growthsJanuary 30, 2023 | Investing Trends (Ad)Profit From the Commercial Solar Boom?Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. January 13, 2023 | marketwatch.comHealthcare Revenue Cycle Management Software Market (New Report) 2023 To Garner Overwhelming Hike In Revenues by 2029 | 121 Pages ReportJanuary 9, 2023 | finance.yahoo.comR1 RCM Inc. (NASDAQ:RCM) Shares Could Be 37% Below Their Intrinsic Value EstimateJanuary 9, 2023 | markets.businessinsider.comAnalysts Offer Insights on Services Companies: R1 RCM (RCM) and Visa (V)January 5, 2023 | marketwatch.comR1 RCM Backs FY22 Outlook, Guides for FY23 Revenue BoostJanuary 5, 2023 | finance.yahoo.comR1 RCM Announces Leadership Appointments; Reaffirms 2022 Guidance and Announces 2023 OutlookDecember 22, 2022 | finance.yahoo.comR1 RCM to Present at the 41st Annual J.P. Morgan Health Care ConferenceDecember 22, 2022 | seekingalpha.comPediatrix: RCM Overhang Now Too Heavy, Revise To HoldDecember 21, 2022 | marketwatch.comHealthcare Revenue Cycle Management Software Market Analysis Report 2023 Along with Statistics Figures, Forecasts till 2029December 20, 2022 | finance.yahoo.comIs R1 RCM Inc.'s (NASDAQ:RCM) Stock Price Struggling As A Result Of Its Mixed Financials?December 14, 2022 | seekingalpha.comR1 RCM: Reversal Rally Well Supported In The DataDecember 12, 2022 | uk.finance.yahoo.comRevenue Cycle Management (RCM) Global Market Report 2022: Ukraine-Russia War ImpactDecember 8, 2022 | msn.comHere's How Much $100 Invested In R1 RCM 5 Years Ago Would Be Worth TodayDecember 5, 2022 | markets.businessinsider.comWhat 9 Analyst Ratings Have To Say About R1 RCMDecember 5, 2022 | msn.com9 Analysts Have This to Say About R1 RCMDecember 2, 2022 | wsj.comSecurities Investigation: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Investors of R1 RCM Inc. (RCM)November 30, 2022 | marketwatch.comHealthcare RCM Outsourcing Market Outlook 2022 and Forecast to 2028 with Top Countries DataNovember 30, 2022 | finance.yahoo.comWhy Shares of R1 RCM rose 10% on TuesdayNovember 23, 2022 | marketwatch.comInvestigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Investors of R1 RCM Inc. (NASDAQ: RCM)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Company Calendar Last Earnings11/08/2022Today1/30/2023Next Earnings (Confirmed)2/16/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Management services Sub-IndustryHealth Care Services SectorBusiness Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees22,000Year Founded2003Price Target and Rating Average Stock Price Forecast$17.64 High Stock Price Forecast$32.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+26.1%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$0.06 Trailing P/E Ratio233.17 Forward P/E RatioN/A P/E Growth3.08Net Income$97.20 million Net Margins0.93% Pretax Margin1.02% Return on Equity4.77% Return on Assets2.28% Debt Debt-to-Equity Ratio0.63 Current Ratio1.56 Quick RatioN/A Sales & Book Value Annual Sales$1.47 billion Price / Sales3.95 Cash Flow$0.63 per share Price / Cash Flow22.30 Book Value$1.25 per share Price / Book11.19Miscellaneous Outstanding Shares416,510,000Free Float152,027,000Market Cap$5.83 billion OptionableNot Optionable Beta0.69 Social Links Key ExecutivesLee RivasChief Executive Officer & DirectorJohn SparbyPresidentJennifer WilliamsChief Financial Officer & TreasurerHarvey EwingChief Information Officer & Executive VPJay SreedharanChief Technology & Digital Officer, Executive VPKey CompetitorsExlServiceNASDAQ:EXLSStantecNYSE:STNFTI ConsultingNYSE:FCNEvoqua Water TechnologiesNYSE:AQUALumen TechnologiesNYSE:LUMNView All CompetitorsInsiders & InstitutionsRice Hall James & Associates LLCSold 91,208 shares on 1/27/2023Ownership: 0.019%Comerica BankSold 813 shares on 1/26/2023Ownership: 0.015%Oak Ridge Investments LLCSold 159,923 shares on 1/24/2023Ownership: 0.056%Eudaimonia Partners LLCBought 12,500 shares on 1/24/2023Ownership: 0.003%Crossmark Global Holdings Inc.Bought 3,425 shares on 1/19/2023Ownership: 0.009%View All Insider TransactionsView All Institutional Transactions RCM Stock - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price forecast for 2023? 12 brokers have issued twelve-month price targets for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $32.00. On average, they predict the company's stock price to reach $17.64 in the next year. This suggests a possible upside of 24.9% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2023? R1 RCM's stock was trading at $10.95 on January 1st, 2023. Since then, RCM shares have increased by 29.0% and is now trading at $14.13. View the best growth stocks for 2023 here. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023. View our RCM earnings forecast. How can I listen to R1 RCM's earnings call? R1 RCM will be holding an earnings conference call on Thursday, February 16th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) announced its earnings results on Tuesday, November, 8th. The healthcare provider reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.18. The healthcare provider earned $496 million during the quarter, compared to the consensus estimate of $522.29 million. R1 RCM had a trailing twelve-month return on equity of 4.77% and a net margin of 0.93%. What guidance has R1 RCM issued on next quarter's earnings? R1 RCM updated its FY 2022 earnings guidance on Friday, January, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.79 billion-$1.80 billion, compared to the consensus revenue estimate of $1.79 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). What is R1 RCM's stock symbol? R1 RCM trades on the NASDAQ under the ticker symbol "RCM." Who are R1 RCM's major shareholders? R1 RCM's stock is owned by a number of retail and institutional investors. Top institutional investors include Oak Ridge Investments LLC (0.06%), Tealwood Asset Management Inc. (0.02%), Rice Hall James & Associates LLC (0.02%), Comerica Bank (0.01%), Crossmark Global Holdings Inc. (0.01%) and Congress Asset Management Co. MA (0.01%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Albert Rene Zimmerli, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Michael C Feiner and Richard B Jr Evans. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is R1 RCM's stock price today? One share of RCM stock can currently be purchased for approximately $14.13. How much money does R1 RCM make? R1 RCM (NASDAQ:RCM) has a market capitalization of $5.89 billion and generates $1.47 billion in revenue each year. The healthcare provider earns $97.20 million in net income (profit) each year or $0.06 on an earnings per share basis. How many employees does R1 RCM have? The company employs 22,000 workers across the globe. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More How can I contact R1 RCM? R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049. This page (NASDAQ:RCM) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.